Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting GM1-ganglioside

Details for Australian Patent Application No. 2002305066 (hide)

Owner Albert Einstein College of Medicine of Yeshiva University

Inventors Shen, Ke-Fei; Crain, Stanley M.

Agent Shelston IP

Pub. Number AU-B-2002305066

PCT Number PCT/US02/08472

PCT Pub. Number WO2002/076388

Priority 60/278,529 23.03.01 US

Filing date 19 March 2002

Wipo publication date 8 October 2002

Acceptance publication date 20 December 2007

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/00 (2006.01)

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/215 (2006.01)

A61K 31/4465 (2006.01) - only substituted in position 4

A61K 31/451 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61K 31/4748 (2006.01) - forming part of bridged ring systems

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 33/00 (2006.01) Medicinal preparations containing inorganic active ingredients

A61K 33/04 (2006.01) Medicinal preparations containing inorganic active ingredients - Sulfur, selenium or tellurium

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 38/33 (2006.01) Medicinal preparations containing peptides - derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/278,529 23.03.01 US

27 March 2003 Application Open to Public Inspection

  Published as AU-B-2002305066

20 December 2007 Application Accepted

  Published as AU-B-2002305066

17 April 2008 Standard Patent Sealed

13 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002305067-PYRALOPYRIDINES, PROCESS FOR THEIR PREPARATION AND USE AS THERAPTEUTIC COMPOUNDS

2002305065-METHOD FOR DEPOSITING A COATING HAVING A RELATIVELY HIGH DIELECTRIC CONSTANT ONTO A SUBSTRATE